Jeff Settleman
Impact in
- Oncology top 0.05%
- HER2/EGFR in Cancer Research
- Cancer Cells and Metastasis
- Colorectal Cancer Treatments and Studies
- Lung Cancer Research Studies
- Cancer Research top 0.1%
- Cancer Genomics and Diagnostics
Papers in
-
- PI3K/AKT/mTOR signaling in cancer 10
- Epigenetics and DNA Methylation 6
- Melanoma and MAPK Pathways 6
- Oncology 28
- HER2/EGFR in Cancer Research 9
- Cancer-related Molecular Pathways 8
- Colorectal Cancer Treatments and Studies 5
- Co-authors
- Anurag Singh (6 shared papers)Daniel A. Haber (9 shared papers)Raffaella Sordella (5 shared papers)Daphne W. Bell (5 shared papers)Brian W. Brannigan (4 shared papers)Ross A. Okimoto (3 shared papers)Sara M. Haserlat (2 shared papers)Patricia L. Harris (2 shared papers)
- Journals
- Cancer Research (9 papers)Cancer Cell (6 papers)Cell (5 papers)Clinical Cancer Research (4 papers)Nature (3 papers)
- Partner nations
- United StatesFranceCanada
In The Last Decade
Jeff Settleman
66 papers receiving 20.7k citations
Jeff Settleman's Hit Papers
Peers
Comparison fields: 5 of 154
- Oncology 8.9k
- Cancer Research 4.4k
- Pulmonary and Respiratory Medicine 7.6k
- Molecular Biology 9.8k
- Pathology and Forensic Medicine 1.2k
Countries citing papers authored by Jeff Settleman
This map shows the geographic impact of Jeff Settleman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jeff Settleman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jeff Settleman more than expected).
Fields of papers citing papers by Jeff Settleman
This network shows the impact of papers produced by Jeff Settleman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jeff Settleman. The network helps show where Jeff Settleman may publish in the future.
Co-authors
The 25 scholars most cited alongside Jeff Settleman, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 67 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Activating Mutations in the Epidermal Growth Factor Receptor Underlying Responsiveness of Non–Small-Cell Lung Cancer to Gefitinib Hit paper breakdown → | 2004 | 9243 |
| 2 | EMT, cancer stem cells and drug resistance: an emerging axis of evil in the war on cancer Hit paper breakdown → | 2010 | 2159 |
| 3 | A Chromatin-Mediated Reversible Drug-Tolerant State in Cancer Cell Subpopulations Hit paper breakdown → | 2010 | 1933 |
| 4 | Widespread potential for growth-factor-driven resistance to anticancer kinase inhibitors Hit paper breakdown → | 2012 | 913 |
| 5 | A Gene Expression Signature Associated with “K-Ras Addiction” Reveals Regulators of EMT and Tumor Cell Survival Hit paper breakdown → | 2009 | 649 |
| 6 | Transcriptional control of autophagy–lysosome function drives pancreatic cancer metabolism Hit paper breakdown → | 2015 | 639 |
| 7 | 2010 | 459 | |
| 8 | Drug Resistance via Feedback Activation of Stat3 in Oncogene-Addicted Cancer Cells Hit paper breakdown → | 2014 | 446 |
| 9 | 2005 | 409 | |
| 10 | Identification of a mutation in the extracellular domain of the Epidermal Growth Factor Receptor conferring cetuximab resistance in colorectal cancer Hit paper breakdown → | 2012 | 383 |
| 11 | 2009 | 380 | |
| 12 | 2009 | 249 | |
| 13 | 2014 | 235 | |
| 14 | 2012 | 227 | |
| 15 | 2003 | 201 | |
| 16 | 2000 | 201 | |
| 17 | 2016 | 192 | |
| 18 | 2016 | 178 | |
| 19 | 2006 | 142 | |
| 20 | 2010 | 132 |
About Jeff Settleman
Jeff Settleman is a scholar working on Molecular Biology, Oncology, Pulmonary and Respiratory Medicine, Cancer Research and Cell Biology, having authored 67 papers that have together received 21.3k indexed citations. Recurring topics across this work include Lung Cancer Treatments and Mutations (16 papers), PI3K/AKT/mTOR signaling in cancer (10 papers), HER2/EGFR in Cancer Research (9 papers), Cancer-related Molecular Pathways (8 papers), Cancer Genomics and Diagnostics (7 papers), Epigenetics and DNA Methylation (6 papers), Melanoma and MAPK Pathways (6 papers) and Colorectal Cancer Treatments and Studies (5 papers). The work is most often cited by research in Oncology (8.9k citations), Cancer Research (4.4k citations), Pulmonary and Respiratory Medicine (7.6k citations), Molecular Biology (9.8k citations) and Pathology and Forensic Medicine (1.2k citations). Jeff Settleman has collaborated with scholars based in United States, France and Canada. Frequent co-authors include Anurag Singh, Daniel A. Haber, Raffaella Sordella, Daphne W. Bell, Brian W. Brannigan, Ross A. Okimoto, Sara M. Haserlat, Patricia L. Harris, Jeffrey G. Supko and David C. Christiani. Their work appears in journals such as Cancer Research, Cancer Cell, Cell, Clinical Cancer Research and Nature.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.